𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New drugs in the future treatment of Parkinson's disease

✍ Scribed by Ruth Djaldetti; Eldad Melamed

Publisher
Springer
Year
2002
Tongue
English
Weight
184 KB
Volume
249
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

New delivery techniques in the drug trea
New delivery techniques in the drug treatment of Parkinson's disease
✍ W. Poewe πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 66 KB

A marked response to oral dopaminergic substitution is one of the diagnostic criteria for idiopathic Parkinson's disease. Oral L-Dopa treatment remains to be the most efficacious and best tolerated way of parkinsonian drug therapy. A majority of patients, however, will develop late complications inc

Future directions in the treatment of Pa
Future directions in the treatment of Parkinson's disease
✍ Anthony H.V. Schapira πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 75 KB

The development of treatment for the symptoms of Parkinson's disease (PD) has been one of the most notable successes of neurology. Dopaminergic therapies in the form of levodopa, dopamine agonists, or monoamine oxidase B inhibitors significantly improve the characteristic motor symptoms of bradykine

Costs of drug treatment in Parkinson's d
Costs of drug treatment in Parkinson's disease
✍ Dr. Richard C. Dodel; Karla M. Eggert; Marika S. Singer; Tobias E. Eichhorn; Oli πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 660 KB

## Abstract Parkinson's disease (PD) has a major socioeconomic impact on society. The chronic, progressive course of the disease, which often leads to severe disability, results in high expenses for the medical resources used for treatment, care, and rehabilitation of patients as well as reduced or

The effect of drug treatment on neurogen
The effect of drug treatment on neurogenesis in Parkinson's disease
✍ Sean S. O'Sullivan; Mary Johnson; David R. Williams; Tamas Revesz; Janice L. Hol πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 176 KB

## Abstract There has been recent interest in the possibility that impaired neurogenesis may contribute to the decline in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease (PD). We have investigated the effects of commonly used treatments for PD on neural stem cell (NSC